Logo

Shopping cart

Confirmation
purchase
Item
Code
Item DescriptionPrice
CER10698Efficacy and safety of canakinumab in patients with Still’s disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups20.00 €
 Subtotal 20.00 €